小檗碱改善血脂抗动脉粥样硬化机制进展
作者:
基金项目:

山西省卫生厅科研课题计划(201202002)


Advance of Improving Blood Lipid and Anti-atherosclerosis Mechanism of Berberine
Author:
  • LV Yi-Rui, ZHANG Yu-Ping, CAO Rong-Hui, and LI Jian-Jun

    LV Yi-Rui, ZHANG Yu-Ping, CAO Rong-Hui, and LI Jian-Jun

    (1.Shanxi Medical University,Taiyuan,Shanxi 030001,China 2.Department of Cardiology,Changzhi City People’s Hospital of Shanxi Medical University,Changzhi,Shanxi 046000,China 3.Chinese Academy of Medical Science & Peking Union Medical College & National Center for Cardiovascular Diseases & Fuwai Hospital & State Key Laboratory of Cardiovascular Disease,Beijing 100037,China)
    在知网中查找
    在百度中查找
    在本站中查找
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    传统中药小檗碱,在我国临床长期作为抗菌药物治疗细菌性腹泻。近10年来,国内外学者对小檗碱抗动脉粥样硬化机制进行了广泛的研究。本文从调节血浆脂质代谢、抑制动脉管壁粥样脂质斑块形成等方面对小檗碱改善血脂、抗动脉粥样硬化机制加以综述。

    Abstract:

    Berberine is a traditional Chinese herbal medicine. As a long term clinical antimicrobial drug, it has been used in treating bacterial diarrhea. In recent ten years, the domestic and foreign scholars have extensively studied on anti-atherosclerosis of berberine. In this paper, improvement of blood lipids of berberine and its mechanism of anti-atherosclerosis are reviewed from regulating blood plasma lipids, suppressing the formation of atheromatous lipid plaque on the arterial wall, and so on.

    参考文献
    相似文献
    引证文献
引用本文

吕医瑞,张玉平,曹荣辉,李建军.小檗碱改善血脂抗动脉粥样硬化机制进展[J].中国动脉硬化杂志,2015,23(04):427~432.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2015-01-04